Literature DB >> 1531120

Enhancement of the lytic activity of cloned human CD8 tumour-infiltrating lymphocytes by bispecific monoclonal antibodies.

A Gorter1, K M Krüse, P I Schrier, G J Fleuren, R J van de Griend.   

Abstract

We have isolated tumour-infiltrating lymphocytes (TIL) clones from a patient with renal cell cancer. The cloning frequency and the effector function were measured. No difference in cloning frequency (r2 = 0.97, frequency = 1:13) was observed between TIL expanded with allogeneic versus autologous feeder cells. Sixty-four clones expanded with autologous feeder cells and 37 clones expanded with allogeneic feeder cells were assayed for cytolytic activity on an autologous primary renal cell carcinoma (RCC) culture, an allogeneic RCC line, and on the K562 and Daudi cell lines. Most of these clones were also phenotyped. Although TIL clones expressing cytotoxic activity for RCC lines could be generated with both feeder cell preparations, none of the clones tested showed specificity for cells from autologous primary RCC cultures. However, in the presence of relevant bispecific MoAbs (alpha OC/TR) all CD8+ TIL clones tested could be induced to lyse autologous RCC cultures. Furthermore, the cytolytic activity of all CD8+ clones tested against allogeneic RCC lines could be induced or further enhanced by alpha OC/TR or CD3/G250 bispecific MoAbs. In contrast, none of the CD4+ clones tested showed lytic activity. Quantitatively the cytotoxic response in the presence of alpha OC/TR or CD3/G250 of CD8+ TIL clones against G250+ and MOv18+ cell lines appears to be associated with the level of antigen expression on the target cells. Our results suggest that: (i) expansion of TIL with allogeneic or autologous feeder cells does not effect the lytic profile of the clones; (ii) the use of bispecific MoAbs may overcome a lack of specificity of cytotoxic T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531120      PMCID: PMC1554219          DOI: 10.1111/j.1365-2249.1992.tb06422.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  Cloning and proliferating precursor frequencies of tumor-infiltrating lymphocytes from human solid tumors.

Authors:  T L Whiteside; S Miescher; L Moretta; V von Fliedner
Journal:  Transplant Proc       Date:  1988-04       Impact factor: 1.066

2.  Activation of human peripheral blood mononuclear cells by anti-T3: killing of tumor target cells coated with anti-target-anti-T3 conjugates.

Authors:  G Jung; C J Honsik; R A Reisfeld; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Functional characterization of T lymphocytes propagated from human lung carcinomas.

Authors:  J T Kurnick; R L Kradin; R Blumberg; E E Schneeberger; L A Boyle
Journal:  Clin Immunol Immunopathol       Date:  1986-03

4.  Cloning of human CD3+ T cells and CD3- natural killer cells and requirements for long-term expansion.

Authors:  R J van de Griend; S P Goedegebuure; B A van Krimpen; R L Bolhuis
Journal:  Transplant Proc       Date:  1988-04       Impact factor: 1.066

5.  Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.

Authors:  S Miescher; T L Whiteside; L Moretta; V von Fliedner
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

6.  Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials.

Authors:  S L Topalian; L M Muul; D Solomon; S A Rosenberg
Journal:  J Immunol Methods       Date:  1987-08-24       Impact factor: 2.303

7.  A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes.

Authors:  S A Rosenberg; P Spiess; R Lafreniere
Journal:  Science       Date:  1986-09-19       Impact factor: 47.728

8.  Human ovarian carcinoma lysis by cytotoxic T cells targeted by bispecific monoclonal antibodies: analysis of the antibody components.

Authors:  D Mezzanzanica; S Canevari; S Ménard; S M Pupa; E Tagliabue; A Lanzavecchia; M I Colnaghi
Journal:  Int J Cancer       Date:  1988-04-15       Impact factor: 7.396

9.  Induction of tumor-cell lysis by bi-specific monoclonal antibodies recognizing renal-cell carcinoma and CD3 antigen.

Authors:  J van Dijk; S O Warnaar; J D van Eendenburg; M Thienpont; E Braakman; J H Boot; G J Fleuren; R L Bolhuis
Journal:  Int J Cancer       Date:  1989-02-15       Impact factor: 7.396

10.  Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.

Authors:  K Itoh; C D Platsoucas; C M Balch
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  1 in total

1.  The development and purification of a bispecific antibody for lymphokine-activated killer cell targeting against the rat colon carcinoma CC531.

Authors:  P J Kuppen; A M Eggermont; K M Smits; J D van Eendenburg; S P Lazeroms; C J van de Velde; G J Fleuren
Journal:  Cancer Immunol Immunother       Date:  1993-06       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.